Zimmer Biomet reports Q4 and FY2022 results; no figure details in filing

ZIMMER BIOMET HOLDINGS, INC.

2022-FY EPS reported $1.10 revenue$6,939,900,000

Company issued press release on February 3, 2023 covering Q4 and full-year 2022 financial performance.
Actual financial results not provided in the 8-K text; refer to attached Exhibit 99.1.
Investors should review the press release for specific revenue, EPS, and segment data.
No forward-looking guidance or material events disclosed in the filing body.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ZIMMER BIOMET HOLDINGS, INC. reported financial results for the quarter and year ended December 31, 2022.

Period: the quarter and year ended December 31, 2022
Result: reported results

Exact text from the filing

On February 3, 2023, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter and year ended December 31, 2022.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

ZIMMER BIOMET HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-001740

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.